Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME. - Chevalier, Thomas; Daste, Amaury; Saada‐Bouzid, Esmaa; Loundou, Anderson; Peyraud, Florent; Lambert, Tiphaine; Le Tourneau, Christophe; Peyrade, Frédéric; Dupuis, Charlotte; Alfonsi, Marc; Fayette, Jérôme; Reure, Juliette; et al. (Cancer Medicine, 2021)